Overview

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety of 2 doses of the transdermal testosterone patch in naturally or surgically menopausal women with low libido who are not receiving systemic estrogen or estrogen progestin therapy.
Phase:
Phase 3
Details
Lead Sponsor:
Warner Chilcott
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate